{"filings":[{"id":2033558,"accession_number":"0001628280-26-052152","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2026-08-04T11:13:54+00:00","items":["2.02","9.01"],"status":"ready","headline":"Strata Critical Medical Q2 revenue $72.5M (+60.7% YoY); net loss $(10.5)M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $72.5M, up 60.7% YoY; Clinical segment contributed $24.3M vs. zero in prior year.","Net loss from continuing ops $(10.5)M (14.5% of revenue) vs. $(3.4)M loss a year ago.","Adjusted EBITDA $7.9M (10.9% margin); operating cash flow $5.7M, free cash flow $2.9M.","Completed bolt-on acquisitions of Louisville Perfusion, Heart/Lung Transplant Recovery, Ohio Valley Perfusion in Q2.","Signed agreement to take over Statline's Transplant Center Organ Placement customer relationships over next year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":834357,"accession_number":"0001628280-26-040342","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2026-06-03T20:25:12+00:00","items":["5.07"],"status":"ready","headline":"Strata Critical Medical stockholders elect directors Heyburn and Lauck, ratify Deloitte, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["William A. Heyburn re-elected with 46,050,902 for, 505,421 withhold, 12,687,496 broker non-votes.","Andrew Lauck re-elected with 39,525,159 for, 7,031,164 withhold, 12,687,496 broker non-votes.","Ratification of Deloitte & Touche as auditor: 58,946,832 for, 65,815 against, 231,172 abstain.","Advisory say-on-pay approved: 38,497,962 for, 8,022,682 against, 35,679 abstain, 12,687,496 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95368,"accession_number":"0001628280-26-030898","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Strata Critical Medical Q1 revenue up 87% to $67.4M; net income $2.4M vs prior loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $67.4M (up 87.4% YoY); net income from cont. ops $2.4M vs loss of $1.6M YoY.","Adjusted EBITDA $6.4M; gross margin improved to 21.0% from 19.6%.","Logistics revenue up 32.4% to $47.6M; Clinical segment contributed $19.8M (new).","Completed bolt-on acquisition of Ohio Valley Perfusion Associates; reiterating full-year 2026 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":67384000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108402,"accession_number":"0001628280-26-013553","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Strata Critical Medical Q4 revenue up 83.5% YoY to $66.8M; raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $66.8M (+83.5% YoY); logistics revenue up 35.3% to $49.2M.","Full year 2025 revenue $197.1M, Adjusted EBITDA $14.1M, both above guidance high end.","Full year 2025 net loss from continuing ops $20.1M vs $16.1M in 2024.","FY2026 revenue guidance raised to $260-275M; Adjusted EBITDA guidance raised to $29-33M.","Clinical segment (Keystone) contributed $17.6M revenue in Q4; total gross profit $14.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108401,"accession_number":"0001104659-26-010689","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Strata Critical Medical secures $30M ABL credit facility from JPMorgan for acquisitions","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered Credit Agreement for up to $30M revolving ABL facility, expandable to $50M subject to conditions.","Facility is undrawn at close; proceeds to be used for working capital and future tuck-in acquisitions.","Owned aircraft excluded from collateral, preserving future financing optionality.","Maturity date January 30, 2029; interest at SOFR plus 2.00% margin.","Springing financial covenant: minimum Fixed Charge Coverage Ratio of 1.05x when availability < greater of $5M or 20% of commitments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124841,"accession_number":"0001104659-25-118180","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-12-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Strata Critical Medical appoints Will Cook to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William L. Cook III appointed as Class I director effective Dec 2, 2025; board expanded from eight to nine directors.","Cook is President & CEO of Vail Health; joins Compensation and Nominating & Governance Committees.","Granted 33,157 RSUs vesting at 2027 annual meeting; standard non-employee director compensation pro-rated.","No family relationships or reportable transactions under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124839,"accession_number":"0001628280-25-054709","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K/A","filed_at":"2025-12-02T23:59:59+00:00","items":["9.01","2.01"],"status":"ready","headline":"Strata Critical Medical amends 8-K to include Keystone financials; acquisition closed","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of Keystone Perfusion Services closed Sep 16, 2025; all equity interests acquired.","Keystone's audited FY2024: revenue $42.9M, net income $2.97M, total assets $16.9M.","Amendment adds historical audited and unaudited financials of Keystone and pro forma combined statements.","Sale of Passenger business to Joby Aero also referenced as part of overall transactions.","Pro forma financials for FY2024, FY2023, and nine months ended Sep 30, 2025 filed as Exhibit 99.3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124840,"accession_number":"0001628280-25-050785","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Strata Critical Medical Q3 revenue up 36.7% to $49.3M; net loss widens to $9.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $49.3M, up 36.7% YoY; organic growth 29.0% excluding Keystone acquisition.","Net loss from continuing ops $(9.7)M, widened from $(5.6)M in prior-year period.","Medical Segment Adjusted EBITDA $7.6M, +93.5% YoY; margin 15.3% (up 450 bps).","Raised FY2025 revenue guidance to $185-195M; reaffirmed Adjusted EBITDA range.","Investor Day on Nov 17, 2025 to introduce FY2026 guidance and medium-term targets."],"consensus_eps_estimate":null,"consensus_eps_actual":0.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":130354000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141545,"accession_number":"0001779128-25-000114","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.01","2.01","9.01","3.02","7.01"],"status":"ready","headline":"Strata completes $124M acquisition of Keystone Perfusion, updates 2025 guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total upfront consideration of $124M (88% cash, 12% stock) at ~9x Keystone's estimated 2025 Adjusted EBITDA of ~$13M.","Up to $23M earn-out payable upon achieving ~25% gross profit growth in each of 2026, 2027, and 2028.","Keystone expected to generate ~$65M revenue and ~$13M Adjusted EBITDA in 2025, with >50% YoY revenue growth.","Updated full-year 2025 guidance: revenue $180-190M, Adjusted EBITDA $13-14M (includes Keystone from Sep 16).","Founder/CEO Louis Verdetto, Michael Hancock, and Christie Campbell remain in current roles post-closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141543,"accession_number":"0001779128-25-000102","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K/A","filed_at":"2025-09-12T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Strata Critical Medical Board sets annual say-on-pay votes until 2031","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders voted for annual say-on-pay frequency at May 6, 2025 meeting.","Compensation Committee determined to hold annual say-on-pay votes until next frequency vote no later than 2031.","Board may reconsider frequency before 2031 if it chooses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141544,"accession_number":"0001104659-25-085185","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["1.01","2.01","5.02","5.03","7.01","8.01","9.01"],"status":"ready","headline":"Strata Critical Medical closes Passenger sale to Joby for ~$76M in stock; shifts to medical transport","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed sale of Passenger business to Joby Aero on Aug 29; received ~$76M in 5.3M Joby shares, plus up to $35M earnout and $10M holdbacks.","Name changed to Strata Critical Medical; Nasdaq tickers become SRTA (common) and SRTAW (warrants).","Melissa Tomkiel and William Heyburn appointed co-CEOs; both join Board; directors Borthwick and Lerer resigned.","Pro forma shows continuing ops net loss of $1.45M for H1 2025 vs $7.24M reported, reflecting Passenger divestiture.","Company issued updated FY2025 financial guidance; see press release Exhibit 99.2 for details."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141542,"accession_number":"0001104659-25-085182","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K/A","filed_at":"2025-08-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Strata Critical Medical appoints Co-CEOs Tomkiel and Heyburn, approves $550K salary and PSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Melissa Tomkiel and William Heyburn became Co-CEOs effective Aug 1, 2025, retaining General Counsel and CFO roles respectively.","Base salary for each Co-CEO increased to $550,000, approved by the Board on Aug 27, 2025.","Each received PSUs with target values: $500,000 based on Passenger business 12-month targets, and $2,000,000 on three-year company performance.","On termination without cause or for good reason, unvested time-vesting equity vests up to 18 months; performance-vesting PSUs vest pro-rata with 548-day add-on."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141541,"accession_number":"0001779128-25-000058","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility Q2 net loss narrows to $3.7M; sells Passenger division to Joby for up to $125M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q2 net loss improved $7.6M YoY to $(3.7)M; Adjusted EBITDA $3.2M vs $0.96M YoY.","Medical revenue grew 17.6% YoY; Medical Adjusted EBITDA $6.0M (+9.3%).","Sells Blade Passenger division to Joby Aviation for up to $125M; Medical becomes standalone public company rebranded as Strata.","Sale expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141540,"accession_number":"0001104659-25-073338","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Blade sells passenger division to Joby for up to $125M; to rebrand as Strata","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Up to $125M consideration (cash or Joby stock): $90M at close plus up to $35M earnout tied to performance and retention.","Blade's medical division remains public and rebrands as Strata, focusing on contractual medical logistics and organ transport.","CEO Rob Wiesenthal joins Joby as CEO of Blade unit, becomes Chairman of Strata; co-CEOs Tomkiel and Heyburn lead Strata.","Transaction expected to be Adjusted EBITDA and FCF neutral; $7M in annual corporate cost efficiencies identified.","Expected close in coming weeks; Blade's Passenger business includes US/Europe operations and the Blade brand."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159391,"accession_number":"0001779128-25-000039","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q1 revenue $54.3M (+5.4% YoY); net loss improves to $(3.5)M; reaffirms FY2025 positive Adj. EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $54.3M (+5.4% YoY); excluding exited Canada, up 10.9%.","Net loss $(3.5)M, improved $0.7M YoY; Adj. EBITDA $(1.2)M, improved $2.3M YoY.","Passenger segment Adj. EBITDA $0.1M, first profitable Q1 since IPO (+$2.7M YoY).","Medical segment Adj. EBITDA $4.1M; new monthly trip volume record set in April 2025.","Reaffirms guidance: double-digit millions of Adjusted EBITDA for full-year 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":54306000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159390,"accession_number":"0001779128-25-000037","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Blade Air Mobility annual meeting elects directors, ratifies auditor, approves say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Three Class I directors elected: John Borthwick (39.3M for, 6.4M withhold), Reginald Love (28.7M for, 17.0M withhold), Edward Philip (43.5M for, 2.2M withhold).","Ratification of Deloitte & Touche as auditor for FY2025 passed with 62.0M for, 62.7K against.","Advisory say-on-frequency vote: 43.7M favored 1-year frequency vs. 1.9M for 3-year.","Advisory say-on-pay approved with 30.0M for, 14.9M against, 680K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177786,"accession_number":"0001779128-25-000007","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility Q4 revenue up 14.5% to $54.4M; Net loss narrows 71% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $54.4M (+14.5% YoY); net loss improved 71% to $(9.8)M from $(33.9)M.","Full-year net loss improved to $(27.3)M from $(56.1)M; Adjusted EBITDA $1.2M vs $(16.6)M prior year.","Medical Segment Q4 Adjusted EBITDA rose 119.6% to $5.5M.","Reaffirmed 2025 guidance for double-digit millions of Adjusted EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194492,"accession_number":"0001779128-24-000123","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility Q3 revenue $74.9M (+4.8%); net loss $(2.0)M; Adj EBITDA $4.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $74.9M, up 4.8% YoY; gross margin improved 520 bps to 19.3%.","Net loss $(2.0)M vs income $0.3M YoY; Adjusted EBITDA $4.2M, improvement of $3.4M.","Operating cash flow $6.4M, up $4.3M; free cash flow before aircraft acquisitions $3.7M, up $2.4M.","Medical segment Adj EBITDA improved 15.1%; Passenger segment Adj EBITDA up $2.8M, achieving trailing 12-month profitability.","Reaffirmed guidance: positive Adjusted EBITDA in 2024 and double-digit millions in 2025; announced strategic alliance with OrganOx."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":194336000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210822,"accession_number":"0001779128-24-000095","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility Q2 net loss narrows to $11.3M; first public Q2 with positive Adj. EBITDA $1.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $11.3M improved $0.9M YoY; revenue $67.9M up 11.4% YoY.","Adjusted EBITDA positive $1.0M vs. -$4.4M prior year; first positive Q2 as public company.","Medical segment revenue record $38.3M (6.4% sequential growth); Medical Adj. EBITDA record $5.5M (+82.7% YoY).","Passenger segment posted first positive Q2 Adjusted EBITDA of $0.8M, improving $2.9M YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":119459000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229227,"accession_number":"0001779128-24-000064","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Blade Air Mobility stockholders elect directors and ratify auditor at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Susan Lyne elected as Class III director with 28,648,946 for, 8,168,466 withheld; Robert Wiesenthal with 30,585,817 for, 6,231,595 withheld.","Deloitte & Touche ratified as auditor for FY2024: 46,219,104 for, 884,152 against, 18,752 abstain.","Broker non-votes: 10,304,596 on director election; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229226,"accession_number":"0001779128-24-000062","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q1 net loss narrows to $4.2M; Medical revenue record $36M, up 34.6% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total Q1 revenue of $51.5M, up 13.8% YoY; Medical segment revenue hit a record $36.0M.","Net loss improved to ($4.2M) from ($10.2M) a year ago; Adjusted EBITDA loss narrowed to ($3.5M).","Medical Segment Adjusted EBITDA reached $4.4M (+134.5%); Passenger EBITDA loss improved to ($2.7M).","Company reaffirms FY 2024 Adjusted EBITDA profitability and double-digit millions target for 2025.","Gross profit margin expanded to 11.4% from 7.1%, driven by higher-margin Medical revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":51514000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247816,"accession_number":"0001779128-24-000047","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Blade Air Mobility dismisses Marcum, appoints Deloitte as auditor for FY2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee dismissed Marcum LLP on March 19, 2024; no disagreements on accounting or auditing matters.","Marcum's audit reports for FY2023 were unqualified; material weakness in internal controls was previously disclosed.","Deloitte & Touche LLP appointed on March 20, 2024 as independent auditor for fiscal year ending Dec 31, 2024.","Marcum provided a letter (Exhibit 16.1) agreeing with the Company's statements in this report."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247815,"accession_number":"0001779128-24-000040","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-03-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Blade Air Mobility announces up to $20M share repurchase program; expects FY2024 adj. EBITDA profit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $20M of Class A common stock; program effective through March 31, 2025.","Repurchases to be funded from cash on hand and cash from operations; program may be suspended or discontinued at any time.","Company expects full-year 2024 profitability on an adjusted EBITDA basis, with debt-free balance sheet and significant cash.","Volume and timing of repurchases subject to market conditions, acquisition opportunities, and capital allocation strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247814,"accession_number":"0001779128-24-000012","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q4 revenue up 24.5% to $47.5M; guides for 2024 Adj. EBITDA profitability","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $47.5M (+24.5% YoY); full year revenue $225.2M (+54.1%).","Net loss widened to $(33.9)M in Q4 from $(15.4)M; Adj. EBITDA improved to $(5.2)M from $(8.0)M.","Full year 2023 Adj. EBITDA $(16.6)M; guides for 2024 Adj. EBITDA profitability and 2025 double-digit millions.","Announced pending purchase of eight jet aircraft to support Medical growth; new organ placement service launched.","Medical segment Adj. EBITDA positive $2.5M in Q4, up 57.8% YoY; Passenger Adj. EBITDA loss improved to $(2.6)M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265251,"accession_number":"0001779128-23-000119","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility reports Q3 revenue up 56% to $71.4M; net income $0.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $71.4M (+56% YoY); net income $0.3M vs loss of $9.2M in Q3 2022.","Adjusted EBITDA of $0.8M vs loss of $4.5M YoY; positive free cash flow $1.3M.","Flight Profit $15.6M, Flight Margin 21.8% (+154 bps YoY); Passenger segment net income $0.8M.","Medical segment net loss of $0.1M; Medical Adjusted EBITDA $3.3M, up 123.8% YoY.","Operational milestones: Nice Airport screening, Atlantic City heliport, Helijet orders Beta eVTOL."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":177702000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282451,"accession_number":"0001779128-23-000075","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q2 revenue $61M (+71%), medical $34.4M (+99%), net loss $12.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $61.0M (+71% YoY); medical revenue $34.4M (+99% YoY, +29% sequentially).","Flight Profit $10.4M (+103% YoY); Flight Margin 17.0% vs 14.3%.","GAAP net loss $12.2M vs net income $8.4M in prior-year quarter.","Adjusted EBITDA -$4.4M vs -$6.1M, improved 27%; Medical Adj. EBITDA $3.0M.","Short Distance revenue up 75% YoY, driven by Blade Europe acquisition and organic growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":106260000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301672,"accession_number":"0001779128-23-000056","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Blade Air Mobility holds annual meeting; elects three Class II directors and ratifies auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders elected Eric Affeldt, Andrew Lauck, and Kenneth Lerer as Class II directors for terms expiring at 2026 annual meeting.","Ratification of Marcum LLP as independent auditor for FY 2023 passed with 41,152,498 votes for, 556,045 against, 106,174 abstain.","Broker non-votes of 8,066,080 on director elections; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301671,"accession_number":"0001779128-23-000049","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q1 revenue up 70% to $45.3M; Flight Profit +145% to $7.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Short Distance revenue rose 148% YoY, driven by Blade Europe acquisition, Canada improvement, and Airport demand.","MediMobility Organ Transport revenue up 111% YoY and 24% sequentially, from new transplant centers and existing client growth.","Flight Profit (non-GAAP) increased 145% to $7.2M; company cites leverage and expects YoY Adjusted EBITDA improvement.","Seventh consecutive quarter with results ahead of expectations; no GAAP net income or EPS disclosed in release.","Management highlights strong liquidity and asset-light model, preserving capital for opportunistic acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":45271000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321438,"accession_number":"0001104659-23-039190","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-03-30T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Blade Air Mobility expands board to 9, appoints Lauck (RedBird) and Borthwick as directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 7 to 9 members; Andrew Lauck (RedBird Capital) and John Borthwick (Betaworks) appointed as directors effective March 27, 2023.","Lauck, previously a board observer, will serve on Audit Committee; Borthwick will serve on Nominating and Corporate Governance Committee.","Entered nomination rights agreement with RB Lift (RedBird) allowing them to nominate one director as long as they hold >=5% of outstanding common stock.","Nomination rights agreement effective until 2026 annual meeting or ownership falls below 5% or by written consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321437,"accession_number":"0001779128-23-000025","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-03-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q4 revenue $38.1M (+55% YoY); FY revenue $146.1M (+118%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $38.1M, up 55% YoY; FY revenue $146.1M, up 118% YoY.","Short Distance revenue up 51% in Q4; MediMobility Organ Transport revenue up 120% in Q4.","Flight Profit increased 38% in Q4, driven by organic and inorganic growth.","Completed first piloted EVA test flight in NYC with BETA Technologies.","Management expects cash balance available for acquisitions; path to profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321436,"accession_number":"0001104659-23-026703","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Delaware Court validates Blade's capitalization under Section 205","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Court of Chancery approved petition on Feb 27, 2023, validating Second Amended and Restated Certificate of Incorporation.","Order declares all securities issued in reliance on the certificate as validated effective from original issuance.","Resolves potential uncertainty from a prior court ruling regarding company's capitalization.","Company filed the petition on Feb 8, 2023; hearing held Feb 27, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321435,"accession_number":"0001104659-23-018851","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-02-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Blade Air Mobility files Delaware petition to validate stock increase; hearing Feb 27","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["On Feb 8, 2023, Blade filed a Section 205 petition with the Delaware Court of Chancery to validate its 2021 increase in authorized Class A common stock from 100M to 400M shares.","A recent Delaware ruling created uncertainty about whether a separate Class A vote was required for the amendment.","If the court does not validate the increase, it could materially impair Blade's ability to complete equity financing, issue stock-based compensation, or execute its business plan.","Hearing on the petition is set for February 27, 2023 at 10 AM ET in Wilmington, Delaware.","The company continues to believe a separate vote was not required but seeks to resolve uncertainty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321434,"accession_number":"0001779128-23-000007","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2023-01-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Blade revenue jumps to $24.6M in transition period; net income positive on warrant gain","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $24.6M for three months ended Dec 31, 2021, up from $8.0M in prior-year period.","Operating loss widened to $10.5M from $2.4M; net income $0.8M includes $10.9M non-cash warrant gain.","Cash and short-term investments total $282M at Dec 31, 2021; cash used in ops $6.0M.","Acquired exclusive rights to Helijet’s scheduled Canadian passenger routes for $12.4M during period.","Fiscal year changed from Sept 30 to Dec 31; audited transition-period financials filed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":146120000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339567,"accession_number":"0001779128-22-000109","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility Q3 revenue up 125% to $45.7M; Flight Profit up 108%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $45.7M (+125% YoY); Short Distance up 52%, MediMobility up 801%.","Flight Profit $9.3M (+108%); Flight Margin 20.3% (down from 22.0% YoY due to mix shift).","Net loss $9.2M unchanged; Adjusted EBITDA $(4.5)M improved to (9.9)% of revenue from (15.5)%.","Completed Blade Europe acquisition for $48.1M cash; now largest urban air mobility company across 3 continents.","MediMobility serves 67 transplant centers; pro forma organic revenue growth of 174% versus prior year."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":107985000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356921,"accession_number":"0001104659-22-098050","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-09-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Blade completes €47.8M acquisition of Monacair, Héli Sécurité, Azur","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed acquisition of commercial passenger transport activities of Monacair, Héli Sécurité, and Azur.","Aggregate cash purchase price of €47.8 million (approx. $47.6 million).","Acquired via wholly-owned French subsidiary Blade Europe; renamed Blade France and Blade Monaco.","Transaction initially announced on May 18, 2022; closed on September 1, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356920,"accession_number":"0001779128-22-000081","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q2 revenue up 175% to $35.6M; net income $8.4M vs loss year ago","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $35.6M, up 175% YoY; MediMobility revenue $17.2M (+1,013%) driven by Trinity acquisition.","Short Distance revenue $11.0M (+89%) on Helijet acquisition and higher pricing; Flight Margin 14.3% vs 23.0% YoY.","Net income $8.4M vs net loss $24.3M year ago; adjusted EBITDA loss $(6.1)M vs $(2.6)M.","Europe acquisitions of three urban air mobility operators expected to close late Summer 2022.","JetBlue partnership launched June 23; Blade Airport service run-rate above pre-pandemic levels."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":62263000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375415,"accession_number":"0001104659-22-062713","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-05-19T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Blade to acquire three European air mobility operators for €48M cash; largest helicopter passenger service in Europe","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price €48M (US$50M) for asset-light commercial activities of Monacair, Héli Sécurité, and a third operator.","Acquired entities generated €30M revenue and served ~125,000 fliers in 2019; deal expected to close by Summer 2022.","Deal should immediately contribute free cash flow and accelerate Blade's timeline to profitability.","Blade becomes exclusive customer of Air Carriers; will brand flights and create terminals at 10+ European vertiports.","Monacair CEO Damien Mazaudier to join Blade Europe executive team overseeing transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375414,"accession_number":"0001779128-22-000044","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q1 revenue up 187% to $26.6M; net loss widens to $11.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $26.6M, +187% YoY; MediMobility and Jet revenue $22.1M, +186%.","Net loss $11.0M vs $4.2M; flight margin fell to 11% from 16%.","Adjusted EBITDA -$7.7M vs -$2.2M, driven by higher G&A and public company costs.","Blade Airport achieved record weekly run-rate of ~25,000 passengers in May.","Added 14 new organ transport clients in Q1; formed Blade Europe in Paris."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":26630000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375413,"accession_number":"0001779128-22-000036","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-05-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Blade Air Mobility annual meeting elects directors, ratifies auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class I directors Reginald Love (35.5M for) and Edward Philip (33.6M for) elected to board.","Ratification of Marcum LLP as independent auditor for FY2022: 49.1M for, 424k against.","Broker non-votes of 14.1M on director election; no broker non-votes on auditor ratification.","Meeting held May 4, 2022; proposals as described in March 22, 2022 proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":393776,"accession_number":"0001779128-22-000020","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-02-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q4 revenue $24.6M (+208% YoY); net income $0.8M; FY21 rev $67.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $24.6M, up 208% YoY; Short Distance $6.2M (+191%); MediMobility & Jet $18.0M (+227%).","Net income $0.8M vs loss of $2.4M; adjusted EBITDA -$5.9M vs -$1.0M in prior year.","Flight margin 16% in Q4 vs 20% prior year, driven by Blade Airport ramp below breakeven.","FY2021 revenue $67.2M, up 156% YoY; total fliers +215% YoY.","Omicron impact limited in Dec quarter; Blade Airport run-rate dropped to ~5,000 in early Jan from ~20,000 in Dec."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":24618000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":393775,"accession_number":"0001779128-22-000008","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2022-02-02T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Board changes fiscal year from Sept 30 to Dec 31; abbreviates FY2021","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Effective immediately, fiscal year end changed from September 30 to December 31.","Abbreviated transition period from October 1, 2021 through December 31, 2021.","First full calendar fiscal year will be the year ending December 31, 2022.","Fiscal quarters will remain calendar quarters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":412313,"accession_number":"0001779128-21-000016","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2021-12-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Q4 revenue up 144% to $20.3M; full-year $50.5M; acquires Trinity Air and Helijet","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $20.3M (+144% YoY, +28% vs pre-covid 2019); full-year revenue $50.5M (+116% YoY, +62% vs FY2019).","Net loss widened to $9.2M from $0.7M; Adj. EBITDA loss $3.2M; $305M cash for acquisitions and expansion.","Short Distance revenues up 261% to $13.4M; MediMobility and Jet revenues up 50% to $6.6M.","Completed acquisitions of Trinity Air (organ transport) and Helijet's scheduled business (Vancouver) in Q4.","Re-launched Newark Airport service; long-term sub-terminal agreement at Newark through 2028."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":412312,"accession_number":"0001104659-21-145694","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2021-12-02T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Blade pays $12M for exclusive rights to Helijet's scheduled passenger business in Canada","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deal includes exclusive rights to Helijet's scheduled flights and heliport terminals in Vancouver, Victoria, Nanaimo.","Blade gains option to acquire up to 49% of Pacific Heliport Services Ltd, which manages the heliports.","Helijet flew ~100,000 passengers and generated ~$15M revenue in 2019; currently at ~50% pre-pandemic run-rate.","Initial term through 2026, auto-renewing for two-year periods; Helijet to operate all Blade-designated aircraft.","Blade to invest in heliport infrastructure and electric charging for future EVA integration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":431014,"accession_number":"0001104659-21-119291","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2021-09-24T23:59:59+00:00","items":["5.02","8.01","7.01","9.01"],"status":"ready","headline":"Blade Air Mobility appoints Reggie Love to board replacing David Zaslav","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Reginald Love appointed independent director effective Sep 22, 2021; Class I director term expiring at next annual meeting.","Love is a Senior Advisor at Apollo Global Management; will serve on Nominating and Corporate Governance Committee.","David Zaslav resigned as Class I director; resignation not due to any disagreement with the company.","Board approved non-employee director compensation: annual equity/cash award of $150,000; committee chairs get additional $25,000.","Love replaces Zaslav, the largest outside individual shareholder and initial seed investor in Blade."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":431013,"accession_number":"0001104659-21-116671","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2021-09-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Blade completes acquisition of Trinity Air Medical for ~$23M upfront","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed on Sept 15, 2021; pays ~$23M upfront plus contingent earn-out based on EBITDA growth over 3 years.","Trinity generated ~$16M revenue in CY 2020; provides nationwide organ logistics and transportation.","100% of Trinity's capital stock acquired; expands Blade's medical logistics segment.","Advisors: White & Case for Blade; Frame Law and Seabolt & Vincent for Trinity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":431012,"accession_number":"0001104659-21-114037","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2021-09-09T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Blade Air Mobility to acquire Trinity Air Medical for $23.1M cash; creates largest US organ air transport arranger","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Upfront purchase price of $23.1M in cash; potential earn-out based on EBITDA growth over three years.","Trinity generated ~$16M revenue in 2020 and is profitable; Blade MediMobility growing >60% per year.","Trinity's CEO Seth Bacon and COO Scott Wunsch to lead Blade MediMobility post-close.","Asset-light, multi-modal model; expects to transition to drones/EVA under Blade ownership.","Transaction expected to close during week of September 13, 2021, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":431011,"accession_number":"0001104659-21-105537","cik":1779128,"company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","form_type":"8-K","filed_at":"2021-08-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Blade Air Mobility Q3 revenue up 277% to $13.0M; net loss widens to $24.3M on warrant adjustments","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $13.0M (+277% YoY, +73% vs pre-COVID Q3 2019).","Short distance revenue $5.7M (+810% YoY, -13% vs 2019); MediMobility/jet $6.5M (+147%).","Net loss $(24.3)M vs $(1.3)M prior year, driven by $14.9M warrant liability change and $4.2M listing costs.","Adjusted EBITDA $(2.6)M vs $(1.3)M prior year; excluding public company costs, Comparable Adj. EBITDA $(0.9)M improved.","Re-launched NYC airport transfer in June; annualized run-rate ~10,000 fliers (50% of peak 2019)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":30210000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":541656336.5602605,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}